TY - JOUR T1 - Dr. Favalli, <em>et al</em> reply JF - The Journal of Rheumatology JO - J Rheumatol DO - 10.3899/jrheum.200723 SP - jrheum.200723 AU - Ennio Giulio Favalli AU - Elena Agape AU - Roberto Caporali Y1 - 2020/06/01 UR - http://www.jrheum.org/content/early/2020/06/09/jrheum.200723.abstract N2 - We thank Dr. So, et al1 for the interest in our letter2 and for sharing the results about the coronavirus disease 2019 (COVID-19) in patients with systemic lupus erythematosus (SLE) in Hong Kong1. We agree that the quantification of the risk of infection with severe acute respiratory coronaviruses-2 (SARS-CoV-2) in patients with SLE is a major concern. ER -